|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Foundation Trusts (England) - Chief Executive
- NHS Trusts (England) - Medical Director
- NHS Trusts (England) - Chief Executive
|
|
|
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- Social Care Providers (registered with CAS)
- CMO Urgent Messages - Non-NHS Recipients on Public Health Link
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Consultants in Communicable Diseases
- CMO Urgent Messages - Recipients on Public Health Link
- Director of Public Health
- GP - Locum
- NHS 111 and Out of hours providers
- GP Practices
- Out of hours contacts
- Primary Care Networks
|
| Action category: |
|
Important information for immediate action
|
| Title: |
|
Colchicine in the Management of COVID-19 (SARS-CoV 2) Positive Patients - Trial Use Only
|
| Broadcast content: |
|
Colchicine should not be used in the management of COVID-19 positive patients other than in the context of a trial, or unless there is an additional licensed indication for its use.
|
| Additional information: |
|
NHS England and NHS Improvement Regional Offices: please cascade this alert to Community Pharmacy
|